Spinal Stenosis Clinical Trial
Official title:
Institutional Review Board of Tri-Service General Hospital, National Defense Medical Center
Conventional epidurography (CE) is thought to have insufficient usefulness on percutaneous epidural adhesiolysis (PEA). The investigators aimed to evaluate the association between the outcome of PEA and three dimensional-rotational epidurography (3D-RE). The investigators performed 30 PEA in 26 patients, and evaluated their post-PEA image findings. Two independent clinicians categorized and recorded the occurrence of contrast at intra-canal ventral and extra-foraminal regions on CE; and contrast at dorsal canal (DC), ventral canal (VC), dorsal foramen (DF), and ventral foramen (VF) on 3D-RE. Reproducibility was assessed using intra-class correlation coefficients (ICCs). The symptom relief after one month for the patients receiving PEA and the contrast distribution patterns of CE and 3D-RE and were determined.
Patient Selection. This prospective study protocol was approved by the ethics committee, and
informed consent was obtained from all subjects. The investigators analyzed the medical and
radiographic records included patients who underwent lumbar PEA procedures at a single
university hospital. The inclusion criterion was FBSS and SS with unilateral radiculopathy.
All patients reported a history of discogenic or radicular symptoms refractory to
conservative treatments and epidural steroid injection for a minimum of 6 weeks. Diagnoses
were established using magnetic resonance imaging (MRI) and/or computed tomography (CT)
performed before PEA. The PEA was standardized to all patients receiving the procedure. Each
patient received an epidural injection, and if the symptoms persisted or the relief was
insufficient, the patient received PEA >6-week interval between the epidural steroid
injection. Positive provocative test during PEA was used to confirm the affected spinal level
[11]. All patients underwent CE before and after PEA; and 3D-RE after PEA. Patients with a
history of spinal surgery and those with cauda equina syndrome, bleeding diathesis,
associated somatic or psychiatric disease, vertebral fractures, pregnancy, and tumors or
other underlying systemic diseases that could significantly affect the procedural outcomes were
excluded. The patients had bilateral symptoms and did not react to the provocation during PEA
were also excluded. All procedures were performed by one of the authors (YCH) using the same
procedural protocol.
PEA Procedure. A standard PEA procedure was used to lyse adhesions and achieve nerve
blockades in all patients, as previously described [1,2]. A 1-day standardized protocol was
followed. The patient was placed on a radiolucent table in the prone position, and the
procedure was performed under fluoroscopic guidance. The coccygeal and sacral regions were
disinfected with 10% Betadine, and the surgical site was draped in the usual aseptic manner.
The sacral hiatus was anesthetized with 1% xylocaine. Then, a 13.6-G Coaxial needle was
introduced into the epidural space below the level of S3 with a combined use of US-guidance
and fluoroscopy insurance. The US was provided using a scanner (Xario 100; Toshiba, Tokyo,
Japan) with a 7~18 MHz linear transducer (PLU-1204BT). A total of 0.5 mL of the contrast
agent (Omnipaque, GE Healthcare, Ireland) was instilled to confirm the epidural space. Both
anteroposterior, right-oblique, left-oblique, and lateral fluoroscopic views were obtained.
The investigators also assessed the development of any adverse reactions. On confirmation of
the target for PEA, an angiographic catheter (Cobra 4-Fr; Cordis, USA) and/or coaxial
supporting catheter (Chiba 6-Fr; Cook, USA) was gently inserted toward the target site. Once
it reached the target site, a second CE was obtained by injecting 3 mL of the contrast agent
for the identification of filling defects or cutoff signs surrounding the target area. The
investigators choose the target nerve roots for PEA by clinical dermatome involvement and
provocation tests during PEA. The catheter tip was positioned at the ventral epidural space
of the target site, and in the case of foraminal diseases, was placed at the opening of the
foramen [12]. When the tip of the catheter touched the target site or the contrast agent
exerted pressure on the lesion, patients were asked to report provoked symptoms [4].
According to the surgical records, they frequently reported pain similar to what they had
been suffering. Both mechanical and fluid adhesiolysis were performed. The former was achieved
through pushing, pulling, and rotating movements of the catheter, while the latter was
achieved by the injection of 0.9% normal saline (10 mL). Following PEA, a third CE and 3D-RE
was obtained using 3 mL of the contrast agent. All CE and 3D-RE images were saved in the
Digital Imaging and Communications in Medicine format for future analysis, and the CE and
3D-RE after PEA was used for analysis in our study. Finally, a 40 mg triamcinolone acetonide
(YungShin, Taichung, Republic of China) was slowly injected.
3D-RE technique. After performing PEA, 3D-RE are obtained on a commercial digital bi-plane
angiography system (Allura Xper, Philips). A 240-degree rotation forward and backward of the
tube-camera unit around the patient's longitudinal axis within 4 seconds is performed by
using an acquisition matrix of 1024 x 1024 pixels. The forth and back rotation results in 120
radiographs. Raw data were automatically sent to a dedicated workstation (Philips Xtra vision
workstation), where the rotational projection images are prepared for computed 3D
reconstruction. 2D radiographs are used to determine the volume of interest. After correction
of gain and distortion, a 3D data set is calculated, resulting in 512 transverse
CT-equivalent sections. Depending on the initially chosen volume of interest, the voxel size
varies from 0.1 to 0.6 mm. The investigators used a resolution of 0.14-mm voxel size, which
resulted in a 3D cuboid of 25 x 19 x 25 cm.
Reconstruction time was 30 seconds. Detailed information regarding technical performance and
reconstruction procedure has been reported [13]. Postprocessing techniques provided by the
software included real-time 3D volume rendering and multiplanar reformatting. Real-time 3D
volume rendering creates a 3D model of the examined object. The software allows emphasizing
bony structures or soft tissue by changing intensity, brightness, and opacity of different
X-ray structures. Additionally, rotation of the 3D object in all directions is possible, as
is a virtual stereoscopic view provided by the software in combination with special glasses.
The multiplanar reformatting modus generates virtual sections according to the three main
axes and free defined axes. The section planes can be freely chosen, and curved sectioning is
also possible.
Conventional epidurography and 3D-RE Contrast Distributions. Post-PEA CE contrast patterns
were defined and classified into 2 types according to the system proposed by Park et al. and
Gupta et al.[4,6]: Limited intracanal ventral spread (ICV) and extended extraforaminal spread
(EF) (Figure 1). The investigators defined the contrast distributions into 4 areas by
post-PEA 3D-RE : Dorsal Canal (DC), contrast spread to the dorsal zone of the ipsilateral
epidural space not extending to the neural foramen; Ventral Canal (VC), contrast spread to
the ventral zone of the ipsilateral epidural space not extending to the neural foramen;
Dorsal Foramen (DF), contrast spread to the dorsal zone of the ipsilateral epidural space
extending to the neural foramen; Ventral Foramen (VF), contrast spread to the ventral zone of
the ipsilateral epidural space extending to the neural foramen (Figure 2). The CE and 3D-RE
images were analyzed and recorded by a musculoskeletal radiologist (Y.C.H.) and a surgeon
(C.T.T.) who blinded to the results of the clinical data. The investigators made a consensus
if there was discrepancy between the analyses of these images.
Data collection. All patients were clinically evaluated before and 1 month after PEA by a
nurse specialized in pain management and blinded to the treatment details. The intensity of
leg and back pain prior to PEA was assessed using a subjective visual analog scale (VAS)
calibrated from 0 to 10 (0 = no pain and 10 = the worst pain imaginable). The patients'
symptoms relief was rated using a Likert scale: 5 = greatly relief; 4 = some residual
symptoms and symptoms relief > 50%; 3 = some residual symptoms and symptoms relief = 50%; 2 =
residual symptoms and symptoms relief < 50%; 1 = no symptoms relief. For the comparison of
clinical outcomes according to the symptoms relief, patients with grade 3, grade 4, and grade
5 were assigned to a group exhibiting >= 50% symptoms relief, while patients with grade 1 and
grade 2 were assigned to a group exhibiting < 50% symptoms relief. Regarding the radiation
exposure of PEA, simulations were performed with patient-specific input parameters (weight and
length) and the actual 3D-RE system settings for each frame, including the automatic
modulation of beam energy and dose level, and collimation. Effective dose (ED), which has
been generally accepted single number index reflecting patient radiation risk, was
subsequently calculated using the latest ICRP 103 weighing factors, published in 2007 [14].
StatisticalAnalysis. Age, the duration of discomfort prior to PEA, and VAS scores are
expressed as means ±standard deviations. Demographic data within the two groups of greater
symptoms relief and less were compared by using the chi-square test or the Fisher's exact
test or unpaired t-test. Inter-reader agreement was evaluated using the intra-class
correlation coefficients (ICCs), calculated according to Landis and Koch[15], for the
contrast distribution of CE and 3D-RE. Simple linear regression analysis was used to
determine the prediction of the outcome of PEA by the contrast distribution of CE and 3D-RE.
All statistical analyses were performed using the Statistical Package for the Social Sciences
software (SPSS Inc., Chicago, Illinois, USA). A P value of <0.05 was considered statistically
significant.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06290908 -
RPE-P/TLIF for Lumbar Spinal Stenosis With Instability
|
||
Withdrawn |
NCT03223701 -
Efficacy of Using Solum IV and BMC With GFC in TLIF
|
Phase 4 | |
Recruiting |
NCT03883022 -
Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
|
N/A | |
Completed |
NCT02902380 -
The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery
|
N/A | |
Not yet recruiting |
NCT06024785 -
Vertebropexy - Randomized-controlled Trial
|
N/A | |
Not yet recruiting |
NCT06000319 -
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
|
||
Completed |
NCT02558621 -
New Robotic Assistance System for Spinal Fusion Surgery
|
N/A | |
Completed |
NCT02454400 -
Pre-surgery Physiotherapy for Patients With Specific Low Back Pain
|
N/A | |
Completed |
NCT01377623 -
Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion
|
N/A | |
Completed |
NCT00996073 -
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
|
Phase 2 | |
Terminated |
NCT00974623 -
Bone Graft Materials Observational Registry
|
N/A | |
Completed |
NCT00320619 -
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
|
N/A | |
Completed |
NCT00022776 -
Surgical Versus Nonsurgical Treatment for Spinal Stenosis
|
Phase 3 | |
Completed |
NCT06060821 -
Validity and Reliability of the 2-minute Step Test in Patients With Lumbar Spinal Stenosis
|
||
Recruiting |
NCT04552145 -
Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis
|
N/A | |
Active, not recruiting |
NCT04379921 -
Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch
|
N/A | |
Withdrawn |
NCT04315090 -
Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion
|
||
Completed |
NCT04591249 -
Physical Activity Intervention for Patients Following Lumbar Spine Surgery
|
N/A | |
Recruiting |
NCT04601363 -
Personalized Spine Study Group (PSSG) Registry
|
||
Completed |
NCT04193488 -
Mid-Transverse Process to Pleural (MTP) Block and Erector Spinal Plan (ESP) Block in Spinal Surgery
|
N/A |